Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms

BACKGROUND: Autoimmunity has been reported in patients with severe COVID-19. We investigated whether antinuclear/extractable-nuclear antibodies (ANAs) were present up to a year after infection, and if they were associated with the development of clinically relevant Post-Acute Sequalae of COVID-19 (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Son, Kiho, Jamil, Rameen, Chowdhury, Abhiroop, Mukherjee, Manan, Venegas, Carmen, Miyasaki, Kate, Zhang, Kayla, Patel, Zil, Salter, Brittany, Yuen, Agnes Che Yan, Lau, Kevin Soon-Keen, Cowbrough, Braeden, Radford, Katherine, Huang, Chynna, Kjarsgaard, Melanie, Dvorkin-Gheva, Anna, Smith, James, Li, Quan-Zhen, Waserman, Susan, Ryerson, Christopher J, Nair, Parameswaran, Ho, Terence, Balakrishnan, Narayanaswamy, Nazy, Ishac, Bowdish, Dawn ME, Svenningsen, Sarah, Carlsten, Chris, Mukherjee, Manali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515477/
https://www.ncbi.nlm.nih.gov/pubmed/36137590
http://dx.doi.org/10.1183/13993003.00970-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515477/
https://www.ncbi.nlm.nih.gov/pubmed/36137590
http://dx.doi.org/10.1183/13993003.00970-2022

Ejemplares similares